1-METHYL-4-(3-NITROPYRIDIN-2-YL)PIPERAZINE, 97.0%, 5g

4-Methyl-1-phenyl-3-pyrazolidone>98.0%(HPLC)(T)25g

4-Amino-6-chloropicolinic acid, 97%, 1g

TOLAZAMIDE, 98%, 50mg

Citric acid solution, min. 46%, ultra pure, 5 l, plastic packaging.

(4-(Chloromethyl)phenyl)methanol, 95.0%, 10g

tert-Butyl (1R*,4R*)-4-(4-bromobenzylamino)cyclohexylcarbamate, 1g

DLin-KC2-DMA, 10mg

8-Bromo-7-methoxyquinoline, 95.0%, 1g

1-Acetylpyrrolidine-2-carboxylic acid, 95.0%, 1g

(4-(sec-Butoxy)phenyl)methanol, 95.0%, 5g

tert-Butyl ((2R)-1-(1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl)propan-2-yl)carbamate, 98%, 100mg

(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, 97%, 10g